In the original publication [1], there was a mistake in Figure 9 as published. While preparing wound images of the in vivo study, one image in Figure 9 for the Ceph-treated group was inadvertently misplaced. The reported issue was only in the inadvertent placement/duplication of one representative wound image in the Ceph-treated group in Figure 9. The corrected Figure 9 appears below.
Figure 9.
Wound healing capacity of LNFs in the diabetic/obese NcZ10 mouse model. (A) One single S. aureus-infected wound was created by excision before daily topical treatment with LNFs for 11 days. Ceph and BNFs were used as controls; (B) Graphical representation of wound area closure (%) over time in the three groups of mice. Data are expressed as the mean ± SD. ** p < 0.01, * p < 0.05 are differences considered statistically significant, and # p > 0.05 is considered statistically insignificant.
Email Update
The corresponding author’s email address has been updated. The updated email information is as follows: 20177226002@stu.suda.edu.cn (H.I.); menaateam@gmail.com (F.M.).
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Razzaq, A.; Khan, Z.U.; Saeed, A.; Shah, K.A.; Khan, N.U.; Menaa, B.; Iqbal, H.; Menaa, F. Development of Cephradine-Loaded Gelatin/Polyvinyl Alcohol Electrospun Nanofibers for Effective Diabetic Wound Healing: In-Vitro and In-Vivo Assessments. Pharmaceutics 2021, 13, 349. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
